Investment House LLC’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $250K | Hold |
1,155
| – | – | 0.01% | 212 |
|
|
2026
Q1 | $212K | Sell |
1,155
-575
| -33% | -$106K | 0.01% | 213 |
|
|
2025
Q4 | $304K | Hold |
1,730
| – | – | 0.01% | 185 |
|
|
2025
Q3 | $242K | Hold |
1,730
| – | – | 0.01% | 212 |
|
|
2025
Q2 | $217K | Sell |
1,730
-1,489
| -46% | -$186K | 0.01% | 211 |
|
|
2025
Q1 | $440K | Sell |
3,219
-50
| -2% | -$7.15K | 0.03% | 181 |
|
|
2024
Q4 | $500K | Hold |
3,269
| – | – | 0.03% | 162 |
|
|
2024
Q3 | $634K | Hold |
3,269
| – | – | 0.03% | 161 |
|
|
2024
Q2 | $758K | Hold |
3,269
| – | – | 0.04% | 140 |
|
|
2024
Q1 | $705K | Hold |
3,269
| – | – | 0.04% | 145 |
|
|
2023
Q4 | $846K | Sell |
3,269
-67
| -2% | -$16.5K | 0.06% | 126 |
|
|
2023
Q3 | $857K | Buy |
3,336
+100
| +3% | +$26.7K | 0.07% | 123 |
|
|
2023
Q2 | $922K | Sell |
3,236
-424
| -12% | -$126K | 0.07% | 121 |
|
|
2023
Q1 | $1.02M | Hold |
3,660
| – | – | 0.08% | 114 |
|
|
2022
Q4 | $1.01M | Hold |
3,660
| – | – | 0.09% | 97 |
|
|
2022
Q3 | $977K | Sell |
3,660
-55
| -1% | -$11.7K | 0.09% | 99 |
|
|
2022
Q2 | $758K | Sell |
3,715
-272
| -7% | -$55.6K | 0.07% | 112 |
|
|
2022
Q1 | $840K | Sell |
3,987
-115
| -3% | -$25K | 0.06% | 114 |
|
|
2021
Q4 | $984K | Sell |
4,102
-100
| -2% | -$25.7K | 0.06% | 115 |
|
|
2021
Q3 | $1.19M | Hold |
4,202
| – | – | 0.09% | 107 |
|
|
2021
Q2 | $1.46M | Hold |
4,202
| – | – | 0.1% | 105 |
|
|
2021
Q1 | $1.18M | Sell |
4,202
-1,215
| -22% | -$328K | 0.09% | 110 |
|
|
2020
Q4 | $1.33M | Sell |
5,417
-1,022
| -16% | -$264K | 0.09% | 116 |
|
|
2020
Q3 | $1.83M | Sell |
6,439
-75
| -1% | -$20.9K | 0.14% | 87 |
|
|
2020
Q2 | $1.74M | Sell |
6,514
-75
| -1% | -$22.5K | 0.15% | 91 |
|
|
2020
Q1 | $2.08M | Sell |
6,589
-263
| -4% | -$79.8K | 0.24% | 82 |
|
|
2019
Q4 | $2.03M | Sell |
6,852
-148
| -2% | -$41.1K | 0.19% | 92 |
|
|
2019
Q3 | $1.63M | Sell |
7,000
-1,528
| -18% | -$356K | 0.16% | 94 |
|
|
2019
Q2 | $1.99M | Buy |
8,528
+1,431
| +20% | +$330K | 0.21% | 86 |
|
|
2019
Q1 | $1.68M | Sell |
7,097
-55
| -0.8% | -$17.3K | 0.18% | 92 |
|
|
2018
Q4 | $2.15M | Sell |
7,152
-3,568
| -33% | -$1.14M | 0.27% | 80 |
|
|
2018
Q3 | $3.79M | Sell |
10,720
-476
| -4% | -$164K | 0.4% | 67 |
|
|
2018
Q2 | $3.25M | Buy |
11,196
+186
| +2% | +$52.3K | 0.38% | 69 |
|
|
2018
Q1 | $3.02M | Sell |
11,010
-5
| -0% | -$1.55K | 0.37% | 72 |
|
|
2017
Q4 | $3.51M | Sell |
11,015
-682
| -6% | -$219K | 0.43% | 63 |
|
|
2017
Q3 | $3.66M | Hold |
11,697
| – | – | 0.48% | 65 |
|
|
2017
Q2 | $3.17M | Sell |
11,697
-90
| -0.8% | -$23.8K | 0.43% | 68 |
|
|
2017
Q1 | $3.22M | Buy |
11,787
+433
| +4% | +$122K | 0.45% | 69 |
|
|
2016
Q4 | $3.22M | Sell |
11,354
-60
| -0.5% | -$17.8K | 0.49% | 69 |
|
|
2016
Q3 | $3.57M | Buy |
11,414
+215
| +2% | +$63.7K | 0.54% | 61 |
|
|
2016
Q2 | $2.71M | Sell |
11,199
-145
| -1% | -$38.2K | 0.43% | 75 |
|
|
2016
Q1 | $2.95M | Buy |
11,344
+40
| +0.4% | +$10.6K | 0.47% | 71 |
|
|
2015
Q4 | $3.46M | Sell |
11,304
-250
| -2% | -$71.8K | 0.56% | 63 |
|
|
2015
Q3 | $3.37M | Hold |
11,554
| – | – | 0.59% | 60 |
|
|
2015
Q2 | $4.67M | Sell |
11,554
-52
| -0.4% | -$20.9K | 0.75% | 46 |
|
|
2015
Q1 | $4.9M | Sell |
11,606
-395
| -3% | -$156K | 0.79% | 48 |
|
|
2014
Q4 | $4.07M | Sell |
12,001
-200
| -2% | -$64.7K | 0.66% | 54 |
|
|
2014
Q3 | $4.04M | Sell |
12,201
-435
| -3% | -$143K | 0.67% | 47 |
|
|
2014
Q2 | $3.98M | Sell |
12,636
-67
| -0.5% | -$20.2K | 0.68% | 51 |
|
|
2014
Q1 | $3.88M | Hold |
12,703
| – | – | 0.69% | 51 |
|
|
2013
Q4 | $3.55M | Sell |
12,703
-15
| -0.1% | -$3.88K | 0.64% | 54 |
|
|
2013
Q3 | $3.06M | Buy |
12,718
+275
| +2% | +$61.5K | 0.62% | 62 |
|
|
2013
Q2 | $2.68M | Buy |
+12,443
| New | +$2.66M | 0.58% | 65 |
|
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
Investment House LLC's BIIB Position: Q2 2026 in Review
Investment House LLC held its Biogen (BIIB) position steady in Q2 2026 at 1,155 shares worth $250K. The position accounts for 0.01% of the portfolio, ranked #212.
Investment House LLC first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.9M in Q1 2015. 405 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Investment House LLC held 1,155 shares of Biogen worth $250K as of Q2 2026.
- Investment House LLC left its Biogen share count unchanged in Q2 2026.
- Biogen made up 0.01% of Investment House LLC's portfolio in Q2 2026, its #212 holding.
- Investment House LLC first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Investment House LLC's Biogen position peaked at $4.9M in Q1 2015.
- 405 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Investment House LLC's 13F filing for Q2 2026, filed 21 Jul 2026.